Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Longitudinal Ultrasound Curriculum Improves Long-Term Retention Among Internal Medicine Residents
Kelm, Diana J. , Ratelle, John T. , Azeem, Nabeel , Bonnes, Sara L. , Halvorsen, Andrew J. , Bhagra, Anjali , Oxentenko, Amy S.

Journal of Graduate Medical Education | July 6, 2015 | Volume: 7 | Issue: 3 | Pages: 454-457

10.4300/jgme-14-00284.1 | PMID 26457155 Get It

ABSTRACT Background Point-of-care ultrasound is a rapidly evolving component of internal medicine (IM) residency training. The optimal approach for teaching this skill remains unclear. Objective We sought to determine whether the addition of a longitudinal ultrasound curriculum to a stand-alone workshop for ultrasound training improved knowledge retention in IM residents. Methods We conducted an observational cohort study from July to December 2013. All postgraduate year (PGY)-1 IM residents attended an ultrasound workshop during orientation. Ability to identify static images of ascites, kidney, thyroid, pleural fluid, inferior vena cava, and internal jugular vein was assessed immediately after the workshop. An ultrasound curriculum, including morning report and ultrasound rounds, was initiated during the inpatient medicine rotation. PGY-1 residents were randomly assigned to participate in the longitudinal curriculum. Six months later, we conducted a follow-up survey with all PGY-1 residents. Results Forty-eight PGY-1 residents (67%) completed the postworkshop test and the 6-month follow-up test. Of these, 50% (24 of 48) had participated in the ultrasound curriculum. Residents not exposed to the curriculum showed a decline in the identification of ascites, pleural effusion, and internal jugular vein at 6 months (P < .05), whereas those who participated in the curriculum maintained their performance (P < .05). Conclusions Six months after exposure to a longitudinal ultrasound curriculum, residents were more likely to correctly identify ultrasound images of ascites, kidney, and pleural effusion. The addition of a longitudinal ultrasound curriculum may result in improved knowledge retention in IM residents.
Failure mode and effects analysis to reduce risk of anticoagulation levels above the target range during concurrent antimicrobial therapy
Daniels, Lisa M. , Barreto, Jason N. , Kuth, John C., Anderson, Jeremy R., Majka, Andrew J., Tosh, Pritish K. , Zhang, Beilei, Morgenthaler, Timothy I. , Zhang, Beilei

American Journal of Health-System Pharmacy | July 6, 2015 | Volume: 72 | Issue: 14 | Pages: 1195-1203

10.2146/ajhp140632 | PMID 26150569 Get It

Carotid Endarterectomy for Asymptomatic Stenosis
Howard, George , Meschia, James, Chaturvedi, Seemant , Meschia, James F. , Howard, George

JAMA Internal Medicine | July 6, 2015 | Volume: 175 | Issue: 7 | Pages: 1241

10.1001/jamainternmed.2015.1118 | PMID 26146914 Get It

Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma
Binder, Moritz , Lacy, Martha Q. , Dispenzieri, Angela , Dingli, David , Hayman, Suzanne R. , Lust, John A., Kapoor, Prashant , Lin, Yi , Hwa, Yi L. , Kyle, Robert A. , Kumar, Shaji , Buadi, Francis K. , Rajkumar, S. Vincent , Gertz, Morie A. , Go, Ronald S. , Dispenzieri, Angela , Binder, Moritz , Dingli, David , Lin, Yi

American Journal of Hematology | July 6, 2015 | Volume: 90 | Issue: 10 | Pages: 888-891

10.1002/ajh.24107 | PMID 26148022 Get It

Response to therapy in newly diagnosed symptomatic multiple myeloma (NDMM) can impact long‐term outcomes. It is not clear if baseline laboratory parameters can predict an early, deep response. Totally 1,304 patients with NDMM seen between 2001 and 2013 at Mayo Clinic Rochester were studied. The association between baseline laboratory parameters and early, deep response defined as a very good partial response or better (VGPR+) within four cycles of treatment was investigated. Multivariable logistic regression was used to assess the associations between the parameters of interest and response. Multivariable proportional hazards regression was used to assess the association between response and overall survival. In the entire cohort, greater absolute free light chain (FLC) differences (OR 2.38, 95% CI 1.48–3.82), younger age (OR 2.18, 95% CI 1.28–3.71), lower hemoglobin (OR 1.68, 95% CI 1.12–2.54), and IgA myeloma (OR 1.66, 95% CI 1.10–2.51) were associated with increased odds of achieving VGPR+ after four cycles. Among patients receiving novel agents in general and immunomodulators in particular, these effects were more pronounced. In patients receiving proteasome‐inhibitors, higher creatinine (OR 3.83, 95% CI 1.37–10.1), lower calcium (OR 3.37, 95% CI 1.36–8.35), and greater absolute FLC differences (OR 2.50, 95% CI 1.10–5.71) were associated with better response. In a landmark analysis at 4 months from diagnosis, achieving VGPR+ was associated with decreased risk of subsequent mortality (HR 0.69, 95% CI 0.53–0.86). In summary, several parameters were associated with an early, deep response to treatment, revealing distinct sets of predictors for immunomodulator‐ and proteasome‐inhibitor‐containing regimens. Achieving VGPR+ after four cycles translated into increased overall survival. Am. J. Hematol. 90:888–891, 2015. © 2015 Wiley Periodicals, Inc.
A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy‐associated anemia
Dakhil, Shaker R. , Novotny, Paul J. , Sloan, Jeff A. , Johnson, David B. , Anderson, Daniel M. , Mattar, Bassam, Moore, Dennis F., Nikcevich, Daniel A., Loprinzi, Charles L. , Steensma, David P.

American Journal of Hematology | July 6, 2015 | Volume: 90 | Issue: 10 | Pages: 877-881

10.1002/ajh.24110 | PMID 26149465 Get It

Erythropoiesis‐stimulating agents (ESAs) epoetin alfa (EA) and darbepoetin alfa (DA) increase hemoglobin (Hb) levels and reduce red blood cell (RBC) transfusion requirements in patients with cancer chemotherapy‐associated anemia (CAA). Extended‐interval ESA dosing (administration less than once weekly) is common with DA, but previous studies suggested that EA might also be administered less often than weekly. In this multicenter prospective trial, 239 CAA patients with Hb <10.5 g/dL were randomized to receive EA 40,000 U subcutaneously once weekly (“40K” arm), EA 80,000 U every 3 weeks (“80K”), EA 120,000 U every 3 weeks (“120K” arm), or DA 500 mcg every 3 weeks (“DA”), for 15 weeks. The primary endpoint was the proportion of patients achieving Hb ≥ 11.5 g/dL or increment of Hb > 2.0 g/dL from baseline without transfusion. Secondary endpoints included transfusion requirements, adverse events (AEs), and patient‐reported outcomes (PROs). There were no significant differences between treatment arms in the proportion of patients achieving Hb response (68.9% for 40K, 61.7% for 80K, 65.5% for 120K, and 66.7% for DA; P > 0.41 for all comparisons) or requiring RBC transfusion, but the median Hb increment from baseline was higher in the 40K and DA arms compared to the two extended dosing EA arms, and Hb response was achieved soonest in the weekly EA arm. There were no differences in PROs or AEs. The FDA‐approved schedules tested—weekly EA 40,000 U, and every 3 week DA 500 mcg—are reasonable standards for CAA therapy. Am. J. Hematol. 90:877–881, 2015. © 2015 Wiley Periodicals, Inc.
A flexible, preclinical, medical school curriculum increases student academic productivity and the desire to conduct future research
Peacock, Justin G. , Grande, Joseph P.

Biochemistry and Molecular Biology Education | July 6, 2015 | Volume: 43 | Issue: 5 | Pages: 384-390

10.1002/bmb.20875 | PMID 26148309 Get It

AbstractIn 2006, small blocks of flexible curriculum time, termed selectives, were implemented in the Mayo Medical School preclinical curriculum. Selectives permitted students to pursue professional endeavors, such as research, service, and career exploration, in the preclinical years. The purpose of this study was to survey current and former Mayo medical students regarding the impact of selectives on their research interest and productivity. The authors surveyed 377 current and former Mayo Medical School students from the 2004 to 2014 graduating classes, 154 participants (41% response rate) responded to the survey. The classes were grouped into pre‐ and postselective groups for the comparison studies. Postselective students published significantly more (p = 0.003) and gave significantly more presentations (p = 0.0007) during medical school than preselective students. Thirty‐four (72% of the postselective respondents) indicated that selectives had a strong or very strong impact on their current research interest. Respondents spent an average of 4.0 [3.0–5.0] weeks of Selective time on research, resulting in 1.8 [1.4–2.2] publications and 1.8 [1.4–2.2] presentations, which represented 52.5% [40.0–65.0%] and 47.3% [37.1–57.4%] of the students’ total medical school publications and presentations, respectively. Flexible selective time during the preclinical years results in significantly more medical student academic productivity. © 2015 by The International Union of Biochemistry and Molecular Biology, 43(5):384–390, 2015.
Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes ofClostridium difficileinfection: a systematic review and meta-analysis
Cheungpasitporn, Wisit , Phatharacharukul, Parkpoom , Kaewpoowat, Quanhathai , Mahaparn, Pailin, Bruminhent, Jackrapong , Erickson, Stephen B., Thongprayoon, Charat , Edmonds, Peter J. , Cheungpasitporn, Wisit , Bruminhent, Jackrapong

International Journal of Clinical Practice | July 6, 2015 | Volume: 69 | Issue: 9 | Pages: 998-1006

10.1111/ijcp.12672 | PMID 26147121 Get It

Multivessel Percutaneous Coronary Interventions in the United States
Arora, Shilpkumar , Panaich, Sidakpal , Patel, Nileshkumar , Patel, Nilay , Solanki, Shantanu , Deshmukh, Abhishek , Singh, Vikas , Lahewala, Sopan , Savani, Chirag, Thakkar, Badal, Dave, Abhishek , Patel, Achint , Bhatt, Parth , Sonani, Rajesh, Patel, Aashay, Cleman, Michael , Forrest, John K. , Schreiber, Theodore , Badheka, Apurva O., Grines, Cindy L. , Panaich, Sidakpal S

Angiology | July 5, 2015 | Volume: 67 | Issue: 4 | Pages: 326-335

10.1177/0003319715593853 | PMID 26145455 Get It

Background: Multivessel coronary artery disease carries significant mortality risk. Comprehensive data on inhospital outcomes following multivessel percutaneous coronary intervention (MVPCI) are sparse. Methods: We queried the Healthcare Cost and Utilization Project’s nationwide inpatient sample (NIS) between 2006 and 2011 using different International Classification of Diseases, 9th Revision, Clinical Modification procedure codes. The primary outcome was inhospital all-cause mortality, and the secondary outcome was a composite of inhospital mortality and periprocedural complications. Results: The overall mortality was low at 0.73% following MVPCI. Multivariate analysis revealed that (odds ratio, 95% confidence interval, P value) age (1.63, 1.48-1.79; <.001), female sex (1.19, 1.00-1.42; P = .05), acute myocardial infarction (AMI; 2.97, 2.35-3.74; <.001), shock (17.24, 13.61-21.85; <.001), a higher burden of comorbidities (2.09, 1.32-3.29; .002), and emergent/urgent procedure status (1.67, 1.30-2.16; <.001) are important predictors of primary and secondary outcomes. MVPCI was associated with higher mortality, length of stay (LOS), and cost of care as compared to single vessel single stent PCI. Conclusion: MVPCI is associated with higher inhospital mortality, LOS, and hospitalization costs compared to single vessel, single stent PCI. Higher volume hospitals had lower overall postprocedural mortality rate along with shorter LOS and lower hospitalization costs following MVPCI.
Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location
Yafi, Faysal A. , Knoedler, Margaret , Mandava, Sree Harsha , McCaslin, Ian, Sangkum, Premsant, Sikka, Suresh C. , Trost, Landon , Hellstrom, Wayne J.G. , Stewart, Carrie A, Mandava, Sree H, McCaslin, Ian R, Sikka, Suresh, Stewart, Carrie A.

Journal of Urology | July 5, 2015 | Volume: 194 | Issue: 6 | Pages: 1704-1707

10.1016/j.juro.2015.06.096 | PMID 26144333 Get It

Perinatal Outcomes with Tamsulosin Therapy for Symptomatic Urolithiasis
Bailey, George , Vaughan, Lisa E. , Rose, Carl H., Krambeck, Amy E. , Vaughan, Lisa, Rose, Carl, Krambeck, Amy

Journal of Urology | July 4, 2015 | Volume: 195 | Issue: 1 | Pages: 99-103

10.1016/j.juro.2015.06.097 | PMID 26144335 Get It